This cohort study evaluates the long-term outcomes of splanchnic vein thrombosis in patients with differing risk factors and treatments.
The commentary discusses the implications of the study on anticoagulant therapy for splanchnic vein thrombosis from the International Society on Thrombosis and Hemostasis registry.
Lamontagne and colleagues describe the frequency, anatomical location, risk factors, management, and consequences of nonleg deep venous thromboses in a large cohort of medical-surgical critically ill adults. Maynard provides an Invited Commentary.
Smith et al compare the relative clinical cardiovascular safety of 2 commonly used oral estrogen drugs—conjugated equine estrogens and estradiol. Their case-control study compares cardiovascular event risk among 384 postmenopausal women aged 30 to 79 years using oral hormone therapy. Incident venous thrombosis was the primary clinical outcome.